메뉴 건너뛰기




Volumn 16, Issue 8, 2010, Pages 513-516

High compliance with rotigotine transdermal patch in the treatment of idiopathic Parkinson's disease

Author keywords

Dopamine agonist; Parkinson's disease; Rotigotine; Transdermal patch; Treatment compliance

Indexed keywords

CABERGOLINE; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GAMMA GLUTAMYLTRANSFERASE; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE;

EID: 77956180778     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.06.009     Document Type: Article
Times cited : (35)

References (22)
  • 1
    • 4544289959 scopus 로고    scopus 로고
    • Drug adherence in Parkinson's disease
    • Leopold N.A., Polansky M., Hurka M.R. Drug adherence in Parkinson's disease. Mov Disord 2004, 19:513-517.
    • (2004) Mov Disord , vol.19 , pp. 513-517
    • Leopold, N.A.1    Polansky, M.2    Hurka, M.R.3
  • 2
    • 30444437059 scopus 로고    scopus 로고
    • Suboptimal medication adherence in Parkinson's disease
    • Grosset K.A., Bone I., Grosset D.G. Suboptimal medication adherence in Parkinson's disease. Mov Disord 2005, 20:1502-1507.
    • (2005) Mov Disord , vol.20 , pp. 1502-1507
    • Grosset, K.A.1    Bone, I.2    Grosset, D.G.3
  • 3
    • 33947313314 scopus 로고    scopus 로고
    • Treatment of Parkinson's disease: a survey of patients and neurologists
    • Fargel M., Grobe B., Oesterle E., Hastedt C., Rupp M. Treatment of Parkinson's disease: a survey of patients and neurologists. Clin Drug Invest 2007, 27:207-218.
    • (2007) Clin Drug Invest , vol.27 , pp. 207-218
    • Fargel, M.1    Grobe, B.2    Oesterle, E.3    Hastedt, C.4    Rupp, M.5
  • 4
    • 0034871011 scopus 로고    scopus 로고
    • A systematic review of the associations between dose regimens and medication compliance
    • Claxton A.J., Cramer J., Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001, 23:1296-1310.
    • (2001) Clin Ther , vol.23 , pp. 1296-1310
    • Claxton, A.J.1    Cramer, J.2    Pierce, C.3
  • 5
    • 66249091092 scopus 로고    scopus 로고
    • Adherence to antiparkinson medication in a multicenter European study
    • Grosset D., Antonini A., Canesi M., Pezzoli G., Lees A., Shaw K., et al. Adherence to antiparkinson medication in a multicenter European study. Mov Disord 2009, 24:826-832.
    • (2009) Mov Disord , vol.24 , pp. 826-832
    • Grosset, D.1    Antonini, A.2    Canesi, M.3    Pezzoli, G.4    Lees, A.5    Shaw, K.6
  • 6
    • 0142186036 scopus 로고    scopus 로고
    • Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain
    • Kornick C.A., Santiago-Palma J., Moryl N., Payne R., Obbens E.A. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain. Drug Saf 2003, 26:951-973.
    • (2003) Drug Saf , vol.26 , pp. 951-973
    • Kornick, C.A.1    Santiago-Palma, J.2    Moryl, N.3    Payne, R.4    Obbens, E.A.5
  • 7
    • 23044468859 scopus 로고    scopus 로고
    • Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception
    • Urdl W., Apter D., Alperstein A., Koll P., Schönian S., Bringer J., et al. Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception. Eur J Obstet Gynecol Reprod Biol 2005, 121:202-210.
    • (2005) Eur J Obstet Gynecol Reprod Biol , vol.121 , pp. 202-210
    • Urdl, W.1    Apter, D.2    Alperstein, A.3    Koll, P.4    Schönian, S.5    Bringer, J.6
  • 8
    • 33846438955 scopus 로고    scopus 로고
    • Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease
    • Watts R.L., Jankovic J., Waters C., Rajput A., Boroojerdi B., Rao J. Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease. Neurology 2007, 68:272-276.
    • (2007) Neurology , vol.68 , pp. 272-276
    • Watts, R.L.1    Jankovic, J.2    Waters, C.3    Rajput, A.4    Boroojerdi, B.5    Rao, J.6
  • 9
    • 34248372064 scopus 로고    scopus 로고
    • Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial
    • Poewe W.H., Rascol O., Quinn N., Tolosa E., Oertel W.H., Martignoni E., et al. Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial. Lancet Neurol 2007, 6:513-520.
    • (2007) Lancet Neurol , vol.6 , pp. 513-520
    • Poewe, W.H.1    Rascol, O.2    Quinn, N.3    Tolosa, E.4    Oertel, W.H.5    Martignoni, E.6
  • 10
    • 40849113591 scopus 로고    scopus 로고
    • Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe
    • Oertel W.H., Beneš H., García-Borreguero D., Geisler P., Högl B., Saletu B., et al. Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Med 2008, 9:228-239.
    • (2008) Sleep Med , vol.9 , pp. 228-239
    • Oertel, W.H.1    Beneš, H.2    García-Borreguero, D.3    Geisler, P.4    Högl, B.5    Saletu, B.6
  • 11
    • 49849083845 scopus 로고    scopus 로고
    • Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial
    • Trenkwalder C., Beneš H., Poewe W., Oertel W.H., García-Borreguero D., de Weerd A.W., et al. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2008, 7:595-604.
    • (2008) Lancet Neurol , vol.7 , pp. 595-604
    • Trenkwalder, C.1    Beneš, H.2    Poewe, W.3    Oertel, W.H.4    García-Borreguero, D.5    de Weerd, A.W.6
  • 12
    • 34547404736 scopus 로고    scopus 로고
    • Steady-state pharmacokinetics of rotigotine in patients with early-stage Parkinson's disease
    • (abstract P1245)
    • Braun M., Cawello W., Poole K., Horstmann R. Steady-state pharmacokinetics of rotigotine in patients with early-stage Parkinson's disease. Eur J Neurol 2005, 12(SSSS):37-300. (abstract P1245).
    • (2005) Eur J Neurol , vol.12 , Issue.SUPPL. 2 , pp. 37-300
    • Braun, M.1    Cawello, W.2    Poole, K.3    Horstmann, R.4
  • 13
    • 34247208187 scopus 로고    scopus 로고
    • Advanced Parkinson disease treated with rotigotine transdermal system. PREFER Study
    • LeWitt P.A., Lyons K.E., Pahwa R. Advanced Parkinson disease treated with rotigotine transdermal system. PREFER Study. Neurology 2007, 68:1262-1267.
    • (2007) Neurology , vol.68 , pp. 1262-1267
    • LeWitt, P.A.1    Lyons, K.E.2    Pahwa, R.3
  • 14
    • 50649105757 scopus 로고    scopus 로고
    • Assessing the impact of ease of administration and tolerability on treatment choices in Parkinson's disease
    • Setter S.M. Assessing the impact of ease of administration and tolerability on treatment choices in Parkinson's disease. Neurol Clin 2008, 26:S45-S63.
    • (2008) Neurol Clin , vol.26
    • Setter, S.M.1
  • 15
    • 67649377884 scopus 로고    scopus 로고
    • Available at:, [accessed 03.05.09]
    • ® transdermal patch. Package label Available at:, [accessed 03.05.09]. http://www.emea.europa.eu/humandocs/PDFs/EPAR/neupro/H-626-PI-en.pdf.
    • ® transdermal patch. Package label
  • 16
    • 0022632510 scopus 로고
    • Concurrent and predictive validity of a self-reported measure of medication adherence
    • Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74.
    • (1986) Med Care , vol.24 , pp. 67-74
    • Morisky, D.E.1    Green, L.W.2    Levine, D.M.3
  • 17
    • 0041384468 scopus 로고    scopus 로고
    • The impact of reducing dose frequency on health outcomes
    • Richter A., Anton S.F., Koch P., Dennett S.L. The impact of reducing dose frequency on health outcomes. Clin Ther 2003, 25:2307-2335.
    • (2003) Clin Ther , vol.25 , pp. 2307-2335
    • Richter, A.1    Anton, S.F.2    Koch, P.3    Dennett, S.L.4
  • 18
    • 0024343414 scopus 로고
    • How often is medication taken as prescribed? A novel assessment technique
    • Cramer J.A., Mattson R.H., Prevey M.L., Scheyer R.D., Ouellette V.L. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989, 261:3273-3277.
    • (1989) JAMA , vol.261 , pp. 3273-3277
    • Cramer, J.A.1    Mattson, R.H.2    Prevey, M.L.3    Scheyer, R.D.4    Ouellette, V.L.5
  • 19
    • 77956169807 scopus 로고    scopus 로고
    • Improved self-reported compliance with transdermal (patch) versus oral medication in Parkinson's disease patients
    • (abstract P1175)
    • Grosset D., Grosset K., Emmermann A., Hastedt C., Tischer B. Improved self-reported compliance with transdermal (patch) versus oral medication in Parkinson's disease patients. Eur J Neurol 2006, 13(Suppl. 2):88-89. (abstract P1175).
    • (2006) Eur J Neurol , vol.13 , Issue.SUPPL. 2 , pp. 88-89
    • Grosset, D.1    Grosset, K.2    Emmermann, A.3    Hastedt, C.4    Tischer, B.5
  • 20
    • 61949226675 scopus 로고    scopus 로고
    • Treatments for Parkinson disease past achievements and current clinical needs
    • Poewe W. Treatments for Parkinson disease past achievements and current clinical needs. Neurology 2009, 72:S65-S73.
    • (2009) Neurology , vol.72
    • Poewe, W.1
  • 21
    • 0346754905 scopus 로고    scopus 로고
    • A controlled trial of rotigotine monotherapy in early Parkinson's disease
    • Parkinson Study Group
    • Parkinson Study Group A controlled trial of rotigotine monotherapy in early Parkinson's disease. Arch Neurol 2003, 60:1721-1728.
    • (2003) Arch Neurol , vol.60 , pp. 1721-1728
  • 22
    • 38549159427 scopus 로고    scopus 로고
    • Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole
    • Giladi N., Boroojerdi B., Korczyn A.D., Burn D.J., Clarke C.E., Schapira A.H.V. Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole. Mov Disord 2007, 22:2398-2404.
    • (2007) Mov Disord , vol.22 , pp. 2398-2404
    • Giladi, N.1    Boroojerdi, B.2    Korczyn, A.D.3    Burn, D.J.4    Clarke, C.E.5    Schapira, A.H.V.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.